Use of Proporanolol Compounding from Tablet in Infantile Hemangiomas

dc.contributor.authorYazici, Nalan
dc.contributor.authorSarialioglu, Faik
dc.contributor.authorErbay, Ayse
dc.contributor.orcID0000-0002-8257-810Xen_US
dc.contributor.orcID0000-0003-4465-8229en_US
dc.contributor.pubmedID28612583en_US
dc.contributor.researcherIDAAL-7766-2021en_US
dc.contributor.researcherIDAAM-5138-2021en_US
dc.date.accessioned2023-08-11T08:31:50Z
dc.date.available2023-08-11T08:31:50Z
dc.date.issued2017
dc.identifier.eissn1827-1715en_US
dc.identifier.endpage370en_US
dc.identifier.issn0026-4946en_US
dc.identifier.issue4en_US
dc.identifier.scopus2-s2.0-85020877422en_US
dc.identifier.startpage369en_US
dc.identifier.urihttp://hdl.handle.net/11727/10246
dc.identifier.volume69en_US
dc.identifier.wos000408927800016en_US
dc.language.isoengen_US
dc.relation.isversionof10.23736/S0026-4946.16.04428-5en_US
dc.relation.journalMINERVA PEDIATRICAen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectPROPRANOLOLen_US
dc.titleUse of Proporanolol Compounding from Tablet in Infantile Hemangiomasen_US
dc.typeletteren_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: